Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy.

Nutrients · 2024 · PMC11510382 · PMID 39458464

Europe PMC DOI

hedged sentence

0.0627

closest p · 1.3× alpha

0.0627

boldest claim

The sentences

a nonsignificant trendp = 0.0627so close (0.05 < p ≤ 0.1)

However, PNI showed a nonsignificant trend toward a lower RDI in patients with scores <45 ( p = 0.0627), and no significant correlation was found with the NLR.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.